Health Technology · Pharmaceuticals: Major · NSE: BIOFILCHEM · data 2026-10-09
Biofil Chemicals & Pharmaceuticals Ltd.
Health check: Weak (2.8/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹30.15
Market cap
₹48 cr
P/E
101.3
P/B
—
ROE
13.8%
ROCE
1.8%
Debt / equity
0.14
Dividend yield
0.00%
1-year return
-24.9%
52-week high
₹46.34
52-week low
₹25.6
Operating margin
1.5%
Growth
| Revenue (last 12 months) | ₹34 cr |
| Net profit (last 12 months) | ₹0 cr |
| Sales growth, 3 years (yearly) | -1.9% |
| Profit growth, 3 years (yearly) | 70.7% |
Chart patterns
- Double top — forming (key level ₹30.12)
Similar companies
Zenith Drugs Ltd. (ZENITHDRUG) · Onyx Biotec Ltd. (ONYX) · Vivimed Labs Limited (VIVIMEDLAB) · Mangalam Drugs & Organics Ltd. (MANGALAM) · Medicamen Organics Ltd. (MEDIORG)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open BIOFILCHEM in NSE Scanner →